• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用因果森林评估成本效益分析中的异质性。

Using causal forests to assess heterogeneity in cost-effectiveness analysis.

机构信息

School of Public Health and Community Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.

出版信息

Health Econ. 2021 Aug;30(8):1818-1832. doi: 10.1002/hec.4263. Epub 2021 May 4.

DOI:10.1002/hec.4263
PMID:33942950
Abstract

We develop a method for data-driven estimation and analysis of heterogeneity in cost-effectiveness analyses (CEA) with experimental or observational individual-level data. Our implementation uses causal forests and cross-fitted augmented inverse probability weighted learning to estimate heterogeneity in incremental outcomes, costs and net monetary benefits, as well as other parameters relevant to CEA. We also show how the results can be visualized in relevant ways for the analysis of heterogeneity in CEA, such as using individual-level cost effectiveness planes. Using a simulated dataset and an R package implementing our methods, we show how the approach can be used to estimate the average cost-effectiveness in the entire sample or in subpopulations, explore and analyze the heterogeneity in incremental outcomes, costs and net monetary benefits (and their determinants), and learn policy rules from the data.

摘要

我们开发了一种方法,用于从实验或观察性个体水平数据中对成本效益分析(CEA)中的异质性进行数据驱动的估计和分析。我们的实现使用因果森林和交叉拟合增强逆概率加权学习来估计增量结果、成本和净货币收益以及与 CEA 相关的其他参数的异质性。我们还展示了如何以与 CEA 异质性分析相关的方式对结果进行可视化,例如使用个体水平的成本效益平面。使用模拟数据集和实现我们方法的 R 包,我们展示了如何使用该方法来估计整个样本或子群体中的平均成本效益,探索和分析增量结果、成本和净货币收益(及其决定因素)的异质性,并从数据中学习政策规则。

相似文献

1
Using causal forests to assess heterogeneity in cost-effectiveness analysis.使用因果森林评估成本效益分析中的异质性。
Health Econ. 2021 Aug;30(8):1818-1832. doi: 10.1002/hec.4263. Epub 2021 May 4.
2
An efficient approach for optimizing the cost-effective individualized treatment rule using conditional random forest.利用条件随机森林优化具有成本效益的个体化治疗规则的有效方法。
Stat Methods Med Res. 2022 Nov;31(11):2122-2136. doi: 10.1177/09622802221115876. Epub 2022 Aug 1.
3
Cost-effectiveness and Net Monetary Benefit of Durvalumab Consolidation Therapy Versus No Consolidation Therapy After Chemoradiotherapy in Stage III Non-small Cell Lung Cancer in the Italian National Health Service.度伐利尤单抗巩固治疗与放化疗后不巩固治疗用于意大利国家卫生服务体系中 III 期非小细胞肺癌的成本效果和净货币收益。
Clin Ther. 2020 May;42(5):830-847. doi: 10.1016/j.clinthera.2020.03.012. Epub 2020 Apr 27.
4
Benefit-Cost Analysis in Disease Control Priorities, Third Edition《疾病控制优先事项第三版》中的效益成本分析
5
Cost-effectiveness of ovarian stimulation agents for IUI in couples with unexplained subfertility.在不明原因不孕的夫妇中,用于 IUI 的卵巢刺激药物的成本效益。
Hum Reprod. 2021 Apr 20;36(5):1288-1295. doi: 10.1093/humrep/deab013.
6
Exploring the cost-effectiveness of child dental caries prevention programmes. Are we comparing apples and oranges?探索儿童龋齿预防项目的成本效益。我们是在进行不恰当的比较吗?
Evid Based Dent. 2020 Mar;21(1):5-7. doi: 10.1038/s41432-020-0085-7.
7
Cost-Effectiveness and Net Monetary Benefit of Olaparib Maintenance Therapy Versus No Maintenance Therapy After First-line Platinum-based Chemotherapy in Newly Diagnosed Advanced BRCA1/2-mutated Ovarian Cancer in the Italian National Health Service.在意大利国家卫生服务体系中,一线基于铂类的化疗后,对于新诊断的 BRCA1/2 突变型晚期卵巢癌患者,奥拉帕利维持治疗与无维持治疗的成本效益和净货币收益比较。
Clin Ther. 2020 Jul;42(7):1192-1209.e12. doi: 10.1016/j.clinthera.2020.04.015. Epub 2020 Jun 24.
8
Implementing a thermal care bundle for inadvertent perioperative hypothermia: A cost-effectiveness analysis.实施意外围手术期低体温护理包:成本效益分析。
Int J Nurs Stud. 2019 Sep;97:21-27. doi: 10.1016/j.ijnurstu.2019.04.017. Epub 2019 May 4.
9
Integrating decision modeling and machine learning to inform treatment stratification.整合决策建模和机器学习以提供治疗分层信息。
Health Econ. 2024 Aug;33(8):1772-1792. doi: 10.1002/hec.4834. Epub 2024 Apr 25.
10
The case for stratified cost-effectiveness analysis by baseline health-related QOL: theory and sensitivity analysis.
Pharmacoeconomics. 2005;23(2):121-32. doi: 10.2165/00019053-200523020-00004.

引用本文的文献

1
Applications of artificial intelligence and the challenges in health technology assessment: a scoping review and framework with a focus on economic dimensions.人工智能的应用及卫生技术评估中的挑战:一项范围综述及聚焦经济维度的框架
Health Econ Rev. 2025 Jun 4;15(1):46. doi: 10.1186/s13561-025-00645-4.
2
A Review of Heterogeneity in Comparative Economic Analysis, with Specific Considerations for the Decentralized US Setting and Patient-Centered Care.比较经济分析中的异质性综述,特别考虑美国分散化背景和以患者为中心的医疗。
Pharmacoeconomics. 2025 Jun;43(6):601-616. doi: 10.1007/s40273-025-01478-z. Epub 2025 Mar 8.
3
Understanding the impact of radiotherapy fractionation on overall survival in a large head and neck squamous cell carcinoma dataset: a comprehensive approach combining mechanistic and machine learning models.
在一个大型头颈部鳞状细胞癌数据集中理解放疗分割对总生存期的影响:一种结合机制模型和机器学习模型的综合方法。
Front Oncol. 2024 Aug 13;14:1422211. doi: 10.3389/fonc.2024.1422211. eCollection 2024.
4
Advances in Addressing Patient Heterogeneity in Economic Evaluation: A Review of the Methods Literature.解决经济评价中患者异质性问题的进展:方法文献综述。
Pharmacoeconomics. 2024 Jul;42(7):737-749. doi: 10.1007/s40273-024-01377-9. Epub 2024 Apr 27.
5
An economic evaluation of chronic obstructive pulmonary disease clinical pathway in Saskatchewan, Canada: Data-driven techniques to identify cost-effectiveness among patient subgroups.加拿大萨斯喀彻温省慢性阻塞性肺疾病临床路径的经济评价:在患者亚组中识别成本效益的基于数据的技术。
PLoS One. 2024 Apr 1;19(4):e0301334. doi: 10.1371/journal.pone.0301334. eCollection 2024.
6
Machine learning clinical decision support for interdisciplinary multimodal chronic musculoskeletal pain treatment.用于跨学科多模式慢性肌肉骨骼疼痛治疗的机器学习临床决策支持
Front Pain Res (Lausanne). 2023 May 9;4:1177070. doi: 10.3389/fpain.2023.1177070. eCollection 2023.
7
Assessing the ability of an instrumental variable causal forest algorithm to personalize treatment evidence using observational data: the case of early surgery for shoulder fracture.评估工具变量因果森林算法利用观察数据进行个体化治疗证据的能力:以肩部骨折早期手术为例。
BMC Med Res Methodol. 2022 Jul 11;22(1):190. doi: 10.1186/s12874-022-01663-0.